NHS England has launched guidance on the use of cannabis based products for medicinal use today. The guidance highlights that there is little chance that cannabis based products will be prescribed for kidney patients; these items will only be prescribed in very rare cases of exceptional pain associated with chemotherapy, MS, or for some forms of epilepsy. Only hospital specialists can prescribe and patients who believe that this may be of use to them will need to seek advice from their doctor.
The National Institute for Health and Care Excellence (NICE) is developing further guidance which we welcome, as many kidney patients suffer great pain. We will update you once this guidance has been released.
Information for patients and the public explaining what the changes mean will be available on the Medical Cannabis section of the NHS website from 1 November 2018.
National Peer Support Symposium
Kidney Care UK hosted a National Peer Support Symposium on Thursday 17 November 2022.
NICE consultation on Covid-19 treatments
Kidney Care UK will be working with clinical colleagues to respond to NICE’s consultation, to make sure the v…